Manifestasi Klinis, Manajemen Terapi, Dan Peran Apoteker Dalam Penanganan Long Covid-19

Angela Alysia Elaine; Imam Adi Wicaksono

doi:10.24198/farmaka.v22i2.54100

Manifestasi Klinis, Manajemen Terapi, Dan Peran Apoteker Dalam Penanganan Long Covid-19

Angela Alysia Elaine, Imam Adi Wicaksono

Abstrak

Coronavirus disease 19 (COVID-19) merupakan penyakit yang disebabkan oleh virus sever acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 memiliki beberapa gejala yang akan muncul setelah masa inkubasi virus, seperti gejala ringan berupa demam, batuk kering, rasa lelah, hingga gejala berat seperti kegagalan sistem pernapasan. Gejala-gejala yang muncul dapat membaik dalam waktu 2-6 minggu, tetapi pada beberapa kasus, gejala tersebut dapat bertahan cukup lama hingga beberapa bulan. Long COVID-19 kejadian bertahannya gejala lebih dari 3 bulan setelah pertama kali munculnya gejala COVID-19. Beberapa terapi secara non farmakologi dan farmakologi telah direkomendasikan untuk penanganan manifestasi klinis ataupun gejala yang dirasakan pasien pada kondisi long COVID-19, seperti terapi rehabilitasi, pemberian OAINS, kortikosteroid, bronkodilator, beta bloker, hingga antibiotik. Pemberian terapi tersebut bertujuan untuk mengurangi keparahan gejala, meningkatkan fungsi organ tubuh yang terdampak, dan meningkatkan kualitas hidup dari pasien. Dalam penanganan long COVID-19, tenaga kesehatan berperan penting dalam proses pemberian terapi dan pemantauan efek terapi bagi pasien, sehingga gejala yang persisten dapat berkurang. Sebagai salah satu tenaga kesehatan di Indonesia, apoteker memiliki peran penting dalam penanganan long COVID-19 dengan memberikan informasi dan edukasi terkait long COVID-19 serta penanganannya, optimalisasi penggunaan obat yang rasional, hingga menjaga pengelolaan vitamin, obat, ataupun perbekalan farmasi lainnya agar tidak terjadi kekosongan stok di Indonesia.

Kata kunci: Long COVID-19, manifestasi klinis, terapi, apoteker.

Teks Lengkap:

PDF

Referensi

Augustin, M., Schommers, P., Stecher, M., Dewald, F., Gieselmann, L., Gruell, H., Horn, C., Vanshylla, K., Cristanziano, V. Di, Osebold, L., Roventa, M., Riaz, T., Tschernoster, N., Altmueller, J., Rose, L., Salomon, S., Priesner, V., Luers, J. C., Albus, C., … Lehmann, C. (2021). Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. The Lancet Regional Health - Europe, 6, 100122. https://doi.org/10.1016/j.lanepe.2021.100122

Ayoubkhani, D., Khunti, K., Nafilyan, V., Maddox, T., Humberstone, B., Diamond, I., & Banerjee, A. (2021). Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ, n693. https://doi.org/10.1136/bmj.n693

Banerjee, I., Robinson, J., & Sathian, B. (2022). Treatment of Long COVID or Post COVID syndrome: A pharmacological approach. Nepal Journal of Epidemiology, 12(3), 1220–1223. https://doi.org/10.3126/nje.v12i3.48532

Barker-Davies, R. M., O’Sullivan, O., Senaratne, K. P. P., Baker, P., Cranley, M., Dharm-Datta, S., Ellis, H., Goodall, D., Gough, M., Lewis, S., Norman, J., Papadopoulou, T., Roscoe, D., Sherwood, D., Turner, P., Walker, T., Mistlin, A., Phillip, R., Nicol, A. M., … Bahadur, S. (2020). The Stanford Hall consensus statement for post-COVID-19 rehabilitation. British Journal of Sports Medicine, 54(16), 949–959. https://doi.org/10.1136/bjsports-2020-102596

Bell, S. C., Elborn, J. S., & Byrnes, C. A. (2018). Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention. Respirology, 23(11), 1006–1022. https://doi.org/10.1111/resp.13398

Bellan, M., Soddu, D., Balbo, P. E., Baricich, A., Zeppegno, P., Avanzi, G. C., Baldon, G., Bartolomei, G., Battaglia, M., Battistini, S., Binda, V., Borg, M., Cantaluppi, V., Castello, L. M., Clivati, E., Cisari, C., Costanzo, M., Croce, A., Cuneo, D., … Pirisi, M. (2021). Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge. JAMA Network Open, 4(1), e2036142. https://doi.org/10.1001/jamanetworkopen.2020.36142

Carfì, A., Bernabei, R., & Landi, F. (2020). Persistent Symptoms in Patients After Acute COVID-19. JAMA, 324(6), 603. https://doi.org/10.1001/jama.2020.12603

Cordero, F. M. M., & Pedros, R. M. (2022). Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID-19: (E-SPERANZA). https://clinicaltrials.gov/study/NCT04695704

Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021). Long covid—mechanisms, risk factors, and management. BMJ, n1648. https://doi.org/10.1136/bmj.n1648

Desgranges, F., Tadini, E., Munting, A., Regina, J., Filippidis, P., Viala, B., Karachalias, E., Suttels, V., Haefliger, D., Kampouri, E., Van Singer, M., Tschopp, J., Rochat Stettler, L., Schaad, S., Brahier, T., Hugli, O., Mueller, Y., Gouveia, A., Opota, O., … Boillat-Blanco, N. (2022). Post COVID 19 Syndrome in Outpatients: a Cohort Study. Journal of General Internal Medicine, 37(8), 1943–1952. https://doi.org/10.1007/s11606-021-07242-1

Fernández-de-las-Peñas, C., Rodríguez-Jiménez, J., Cancela-Cilleruelo, I., Guerrero-Peral, A., Martín-Guerrero, J. D., García-Azorín, D., Cornejo-Mazzuchelli, A., Hernández-Barrera, V., & Pellicer-Valero, O. J. (2022). Post–COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Nonhospitalized Patients. JAMA Network Open, 5(11), e2242106. https://doi.org/10.1001/jamanetworkopen.2022.42106

Greenhalgh, T., Knight, M., A’Court, C., Buxton, M., & Husain, L. (2020). Management of post-acute covid-19 in primary care. BMJ, m3026. https://doi.org/10.1136/bmj.m3026

Herman, B., Bruni, A., Zain, E., Dzulhadj, A., & Oo, A. C. (2022). Post-COVID depression and its multiple factors, does Favipiravir have a protective effect? A longitudinal study of indonesia COVID-19 patients. PLOS ONE, 17(12), e0279184. https://doi.org/10.1371/journal.pone.0279184

Hu, B., Guo, H., Zhou, P., & Shi, Z.-L. (2021). Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology, 19(3), 141–154. https://doi.org/10.1038/s41579-020-00459-7

Jadhav, K., & Jariwala, P. (2020). ‘Ivabradin’ versus ‘Carvedilol’ in the management of Post-COVID-19 palpitation with sinus tachycardia. Indian Heart Journal, 72, S33. https://doi.org/10.1016/j.ihj.2020.11.092

Jarrott, B., Head, R., Pringle, K. G., Lumbers, E. R., & Martin, J. H. (2022). “LONG COVID”—A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacology Research & Perspectives, 10(1). https://doi.org/10.1002/prp2.911

Kamal, M., Abo Omirah, M., Hussein, A., & Saeed, H. (2021). Assessment and characterisation of post‐COVID‐19 manifestations. International Journal of Clinical Practice, 75(3). https://doi.org/10.1111/ijcp.13746

Köhler, C. A., Freitas, T. H., Stubbs, B., Maes, M., Solmi, M., Veronese, N., de Andrade, N. Q., Morris, G., Fernandes, B. S., Brunoni, A. R., Herrmann, N., Raison, C. L., Miller, B. J., Lanctôt, K. L., & Carvalho, A. F. (2017). Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis. Molecular Neurobiology. https://doi.org/10.1007/s12035-017-0632-1

Lu, Y., Li, X., Geng, D., Mei, N., Wu, P.-Y., Huang, C.-C., Jia, T., Zhao, Y., Wang, D., Xiao, A., & Yin, B. (2020). Cerebral Micro-Structural Changes in COVID-19 Patients – An MRI-based 3-month Follow-up Study. EClinicalMedicine, 25, 100484. https://doi.org/10.1016/j.eclinm.2020.100484

Lukiw, W. J., Pogue, A., & Hill, J. M. (2022). SARS-CoV-2 Infectivity and Neurological Targets in the Brain. Cellular and Molecular Neurobiology, 42(1), 217–224. https://doi.org/10.1007/s10571-020-00947-7

Mahmoud, M. H., Alghamdi, F. A., Alghamdi, G. A., Alkhotani, L. A., Alrehaili, M. A., & El-Deeb, D. K. (2021). Study of Post-COVID-19 Syndrome in Saudi Arabia. Cureus. https://doi.org/10.7759/cureus.17787

Mahmud, R., Rahman, Md. M., Rassel, M. A., Monayem, F. B., Sayeed, S. K. J. B., Islam, Md. S., & Islam, M. M. (2021). Post-COVID-19 syndrome among symptomatic COVID-19 patients: A prospective cohort study in a tertiary care center of Bangladesh. PLOS ONE, 16(4), e0249644. https://doi.org/10.1371/journal.pone.0249644

Maniscalco, M., Ambrosino, P., Fuschillo, S., Stufano, S., Sanduzzi, A., Matera, M. G., & Cazzola, M. (2021). Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation. Respiratory Medicine, 182, 106401. https://doi.org/10.1016/j.rmed.2021.106401

Méndez, R., Balanzá‐Martínez, V., Luperdi, S. C., Estrada, I., Latorre, A., González‐Jiménez, P., Feced, L., Bouzas, L., Yépez, K., Ferrando, A., Hervás, D., Zaldívar, E., Reyes, S., Berk, M., & Menéndez, R. (2021). Short‐term neuropsychiatric outcomes and quality of life in COVID‐19 survivors. Journal of Internal Medicine, 290(3), 621–631. https://doi.org/10.1111/joim.13262

Mohiuddin Chowdhury, A. T. M., Karim, M. R., Ali, Md. A., Islam, J., Li, Y., & He, S. (2021). Clinical Characteristics and the Long-Term Post-recovery Manifestations of the COVID-19 Patients—A Prospective Multicenter Cross-Sectional Study. Frontiers in Medicine, 8. https://doi.org/10.3389/fmed.2021.663670

Mumoli, N., Bonaventura, A., Colombo, A., Vecchié, A., Cei, M., Vitale, J., Pavan, L., Mazzone, A., & Dentali, F. (2021). Lung Function and Symptoms in Post–COVID-19 Patients. Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 5(5), 907–915. https://doi.org/10.1016/j.mayocpiqo.2021.08.002

Myall, K. J., Mukherjee, B., Castanheira, A. M., Lam, J. L., Benedetti, G., Mak, S. M., Preston, R., Thillai, M., Dewar, A., Molyneaux, P. L., & West, A. G. (2021). Persistent Post–COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment. Annals of the American Thoracic Society, 18(5), 799–806. https://doi.org/10.1513/AnnalsATS.202008-1002OC

Peghin, M., Palese, A., Venturini, M., De Martino, M., Gerussi, V., Graziano, E., Bontempo, G., Marrella, F., Tommasini, A., Fabris, M., Curcio, F., Isola, M., & Tascini, C. (2021). Post-COVID-19 symptoms 6 months after acute infection among hospitalized and non-hospitalized patients. Clinical Microbiology and Infection, 27(10), 1507–1513. https://doi.org/10.1016/j.cmi.2021.05.033

Rogliani, P., Matera, M. G., Page, C., Puxeddu, E., Cazzola, M., & Calzetta, L. (2019). Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine. Respiratory Research, 20(1), 104. https://doi.org/10.1186/s12931-019-1078-y

Seeßle, J., Waterboer, T., Hippchen, T., Simon, J., Kirchner, M., Lim, A., Müller, B., & Merle, U. (2022). Persistent Symptoms in Adult Patients 1 Year After Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study. Clinical Infectious Diseases, 74(7), 1191–1198. https://doi.org/10.1093/cid/ciab611

Sinagra, G., Anzini, M., Pereira, N. L., Bussani, R., Finocchiaro, G., Bartunek, J., & Merlo, M. (2016). Myocarditis in Clinical Practice. Mayo Clinic Proceedings, 91(9), 1256–1266. https://doi.org/10.1016/j.mayocp.2016.05.013

Susanto, A. D., Isbaniah, F., Pratomo, I. P., Antariksa, B., Samoedro, E., Taufik, M., Harinda, F., & Nurwidya, F. (2022). Clinical characteristics and quality of life of persistent symptoms of COVID-19 syndrome in Indonesia. GERMS, 12(2), 158–168. www.germs.ro

Tejerina, F., Catalan, P., Rodriguez-Grande, C., Adan, J., Rodriguez-Gonzalez, C., Muñoz, P., Aldamiz, T., Diez, C., Perez, L., Fanciulli, C., Garcia de Viedma, D., Alcalá, L., Alonso, R., Álvarez, B., Álvarez-Uría, A., Arias, A., Arroyo, L. A., Berenguer, J., Bermúdez, E., … de la Villa, S. (2022). Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infectious Diseases, 22(1), 211. https://doi.org/10.1186/s12879-022-07153-4

Tenforde, M. W., Kim, S. S., Lindsell, C. J., Billig Rose, E., Shapiro, N. I., Files, D. C., Gibbs, K. W., Erickson, H. L., Steingrub, J. S., Smithline, H. A., Gong, M. N., Aboodi, M. S., Exline, M. C., Henning, D. J., Wilson, J. G., Khan, A., Qadir, N., Brown, S. M., Peltan, I. D., … IVY Network Investigators. (2020). Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network - United States, March-June 2020. MMWR. Morbidity and Mortality Weekly Report, 69(30), 993–998. https://doi.org/10.15585/mmwr.mm6930e1

Vollbracht, C., & Kraft, K. (2021). Feasibility of Vitamin C in the Treatment of Post Viral Fatigue with Focus on Long COVID, Based on a Systematic Review of IV Vitamin C on Fatigue. Nutrients, 13(4), 1154. https://doi.org/10.3390/nu13041154

Wang, T. J., Chau, B., Lui, M., Lam, G.-T., Lin, N., & Humbert, S. (2020). Physical Medicine and Rehabilitation and Pulmonary Rehabilitation for COVID-19. American Journal of Physical Medicine & Rehabilitation, 99(9), 769–774. https://doi.org/10.1097/PHM.0000000000001505

Wu, Z., & McGoogan, J. M. (2020). Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA, 323(13), 1239. https://doi.org/10.1001/jama.2020.2648

Xiong, Q., Xu, M., Li, J., Liu, Y., Zhang, J., Xu, Y., & Dong, W. (2021). Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clinical Microbiology and Infection, 27(1), 89–95. https://doi.org/10.1016/j.cmi.2020.09.023

Yong, S. J. (2021). Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infectious Diseases, 53(10), 737–754. https://doi.org/10.1080/23744235.2021.1924397

Zhao, Y., Shang, Y., Song, W., Li, Q., Xie, H., Xu, Q., Jia, J., Li, L., Mao, H., Zhou, X., Luo, H., Gao, Y., & Xu, A. (2020). Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine, 25, 100463. https://doi.org/10.1016/j.eclinm.2020.100463

DOI: https://doi.org/10.24198/farmaka.v22i2.54100

DOI (PDF): https://doi.org/10.24198/farmaka.v22i2.54100.g23492